Login / Signup

Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort study.

Mette NørgaardBianka DarvalicsReimar Wernich Thomsen
Published in: BMJ open (2020)
Compared with sulfonylurea, metformin did not substantially reduce the incidence of BPH in men with diabetes.
Keyphrases
  • benign prostatic hyperplasia
  • lower urinary tract symptoms
  • type diabetes
  • cardiovascular disease
  • risk factors
  • glycemic control
  • middle aged
  • metabolic syndrome